In 2016, it was approved in the U.S. for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in multiple myeloma (MM) patients and the palliative treatment of MM patients for whom oral therapy is not appropriate
Please fill in the details about your medicine requirement on this form.
60/4, T&T House. Yusuf Sarai.
New Delhi:110016 India.
Melphalan hydrochloride is approved to treat Multiple myeloma.
(1) It is used for palliative treatment in patients who cannot take melphalan by mouth. This use is approved for the Alkeran and Evomela brands.
(2) It is used as a conditioning treatment to prepare patients for a stem cell transplant. This use is approved for the Evomela brand.
Global Pharma Network can help you to provide access of Melphalan Hydrochloride medications sold under the brand name for Multiple Myeloma treatment by connecting Patients, Health Care Centers, Pharmacies and Retail Outlets with approved supplier, exporter and distributor of Generic drugs, innovator brands and biosimilar medicines from India. Call Mr. Tarun at +91 8744044044 for more details.
The Global Pharma Network is not an online pharmacy company but we help patient to connect with suppliers in the delivering of Multiple Myeloma medications a pharmaceutical drug (prescription drug, prescription medication or prescription medicine) that legally requires a medical prescription to be dispensed in following countries as per the customer's prescribed medication and applicable regulatory approval.
US Brands Avaialble: Alkeran and Evomela Indian Manaufacturer Brands Avaialble:
Global Pharma Network will help you in importing and exporting this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present. USA, UK, Russia, China, India, Nepal, Bhutan, Myanmar / Burma, Laos, Thailand, Cambodia, Hong Kong, Macau, Malaysia, Indonesia, Middle East, Japan, Philippines.